Published in FEBS Lett on April 24, 1989
Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J (1993) 2.02
Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet (2011) 1.23
Is zinc a neuromodulator? Sci Signal (2008) 1.05
Zn(II)-coordination modulated ligand photophysical processes - the development of fluorescent indicators for imaging biological Zn(II) ions. RSC Adv (2014) 0.83
Transmembrane signals and protooncogene induction evoked by carcinogenic metals and prevented by zinc. Environ Health Perspect (1994) 0.81
Electronic structural dependence of the photophysical properties of fluorescent heteroditopic ligands - implications in designing molecular fluorescent indicators. Org Biomol Chem (2010) 0.79
Toxic metal proteomics: reaction of the mammalian zinc proteome with Cd²⁺. J Inorg Biochem (2014) 0.78
Enhancing the Photostability of Arylvinylenebipyridyl Compounds as Fluorescent Indicators for Intracellular Zinc(II) Ions. J Org Chem (2015) 0.76
Evidence for an extracellular zinc-veneer in rodent brains from experiments with Zn-ionophores and ZnT3 knockouts. ACS Chem Neurosci (2012) 0.76
Potential antileukemic and immunosuppressive drugs. Preparation and in vitro pharmacological acitivity of some benzo-2,1,3-oxadiazoles (benzofurazans) and their N-oxides (benzofuroxans). J Med Chem (1968) 2.39
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
The role of zinc in caspase activation and apoptotic cell death. Biometals (2002) 1.80
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J (1997) 1.70
Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes. Nature (1969) 1.66
7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: a new fluorigenic reagent for amino acids and other amines. Biochem J (1968) 1.65
A subpopulation of human B lymphocytes that rosette with mouse erythrocytes. Clin Exp Immunol (1976) 1.50
Experimental inflammation induced by naturally occurring microcrystalline calcium salts. J Rheumatol (1976) 1.48
Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats. J Lab Clin Med (1998) 1.44
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Biochemical properties of anti-inflammatory drugs. 8. Inhibition of histamine formation catalyzed by substrate specific mammalian histidine decarboxylases. Drug antagonism of aldehyde binding to protein amino groups. Biochem Pharmacol (1966) 1.40
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
Changes in the mucopolysaccharide composition of bovine heart valves with age. Biochem J (1963) 1.32
Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology (1974) 1.30
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
A case report: thoracic duct lymphocyte drainage in rheumatoid arthritis. Clin Immunol Immunopathol (1973) 1.25
Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc. Biochem J (1994) 1.20
Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review. Drug Metab Dispos (1974) 1.19
The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology (1992) 1.15
Biochemical properties of anti-inflammatory drugs. VII. Inhibition of proteolytic enzymes in connective tissue by chloroquine (resochin) and related antimalarial antirheumatic drugs. Biochem Pharmacol (1966) 1.15
Effect of adjuvant disease in rats on cyclophosphamide and isophosphamide metabolism. Biochem Pharmacol (1973) 1.14
New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol (2001) 1.12
Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr (2000) 1.11
Catabolism of 2-methyloctanoic acid and 3beta-hydroxycholest-5-en-26-oic acid. Biochem J (1966) 1.08
Adjuvant disease in rats: biochemical criteria for distinguishing several phases of inflammation and arthritis. Proc Soc Exp Biol Med (1974) 1.07
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Preface. Novel Natural Products: Therapeutic Effects in Pain Arthritis and Gastro-intestinal Diseases. Prog Drug Res (2015) 1.06
Beta-xylosidase and beta-galactosidase activities of mammalian connective tissues and other sources. Nature (1967) 1.05
Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production. Inflamm Res (1996) 1.05
Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol Cell Biol (1999) 1.04
Zinc in health and chronic disease. J Nutr Health Aging (2005) 1.03
Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines. Am J Physiol Lung Cell Mol Physiol (2000) 1.03
Ca2+/Mg(2+)-dependent nuclease: tissue distribution, relationship to inter-nucleosomal DNA fragmentation and inhibition by Zn2+. Biochem Biophys Res Commun (1991) 1.02
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Some biochemical and pharmacological properties of anti-inflammatory drugs. Fortschr Arzneimittelforsch (1965) 1.01
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Physiological role for zinc in prevention of apoptosis (gene-directed death). Biochem Int (1991) 0.99
Anti-inflammatory activity of emu oils in rats. Inflammopharmacology (1997) 0.99
Urate deposition disease. How is it regulated and how can it be modified? Ann Intern Med (1973) 0.98
Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. Carcinogenesis (2000) 0.98
Nonsteroid anti-inflammatory agents. Annu Rev Pharmacol (1973) 0.98
Studies of the human lymphocyte-mouse erythrocyte bond. Clin Exp Immunol (1979) 0.97
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Concerning the pharmacological activity of non-steroid anti-inflammatory drugs: is the acidic function essential? Agents Actions (1973) 0.95
Interaction between nonsteroidal anti-inflammatory drugs and biological membranes-IV. Effects of nonsteroidal anti-inflammatory drugs and of various ions on the availability of sulfhydryl groups on lymphoid cells and mitochondrial membranes. Biochem Pharmacol (1975) 0.95
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Colloidal metallic gold is not bio-inert. Inflammopharmacology (2008) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
The molecular pharmacology of anti-inflammatory drugs: some possible mechanisms of action at the biochemical level. Biochem Pharmacol (1968) 0.91
Concerning the merits of copper aspirin as a potential anti-inflammatory drug. J Pharm Pharmacol (1976) 0.90
Impaired drug metabolism in rats associated with acute inflammation: a possible assay for anti-injury agents. Proc Soc Exp Biol Med (1974) 0.90
Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin. Biol Trace Elem Res (1992) 0.90
Biochemical properties of anti-inflammatory drugs. XII. Inhibition of urate binding to human albumin by salicylate and phenylbutazone analogues and some novel anti-antiflammatory drugs. Biochem Pharmacol (1971) 0.90
Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets. Clin Exp Immunol (1982) 0.89
Zinc and its specific transporters as potential targets in airway disease. Curr Drug Targets (2006) 0.89
Copper and inflammation. Agents Actions (1978) 0.89
Abnormal drug metabolism in rats after an inflammatory insult. Agents Actions (1973) 0.89
B cell leukaemia distinguished from chronic lymphocytic leukaemia by surface markers. Aust N Z J Med (1978) 0.89
Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay. J Rheumatol (1988) 0.88
Esterification of acidic anti-inflammatory drugs suppresses their gastrotoxicity without adversely affecting their anti-inflammatory activity in rats. J Pharm Pharmacol (1980) 0.88
Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity. Agents Actions (1980) 0.87
Ambivalent role of copper in inflammatory disorders. Agents Actions (1976) 0.87
Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites. J Lab Clin Med (1973) 0.87
Concerning the regulation of some diverse biochemical reactions, underlying the inflammatory response, by salicylic acid, phenylbutazone and other acidic antirheumatic drugs. J Pharm Pharmacol (1965) 0.87
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Biodistribution of 64Cu in inflamed rats following administration of two anti-inflammatory copper complexes. Agents Actions (1985) 0.86
A simple immunolatex procedure for light and fluorescence microscopy. Immunobiology (1979) 0.86
Interaction between protein kinase C and regulatory ligand is enhanced by a chelatable pool of cellular zinc. Biochim Biophys Acta (1990) 0.86
Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol (1980) 0.86
Gastroprotective and anti-inflammatory properties of green lipped mussel (Perna canaliculus) preparation. Arzneimittelforschung (1980) 0.86
Improvements for consistently inducing experimental allergic encephalomyelitis (EAE) in rats: I. without using mycobacterium. II. inoculating encephalitogen into the ear. Proc Soc Exp Biol Med (1976) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Gastric mucus effusion elicited by oral copper compounds: potential anti-ulcer activity. Experientia (1976) 0.85
Loss of receptor activity for mouse erythrocytes precedes tumour promoter-induced maturation of chronic lymphocytic leukaemia cells. Cancer Lett (1981) 0.85
Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp Cell Res (1992) 0.85
Lyprinol: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhoea. Allerg Immunol (Paris) (2000) 0.85
Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites? Agents Actions (1993) 0.85
Non-steroid anti-inflammatory drugs: combined assay for anti-edemic potency and gastric ulcerogenesis in the same animal. Life Sci (1977) 0.84
Pharmacology of uricosuric drugs. Ann Rheum Dis (1974) 0.84
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Evaluation of potential antirheumatic drugs in vitro using lymphocytes and epithelial cells. The selective action of indoxole, methyl glyoxal and chloroquine. J Pharm Pharmacol (1967) 0.84
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84
Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro. J Lab Clin Med (1970) 0.83
The chemical synthesis and biological oxidation of 7-alpha-hydroxy[26-14C]cholesterol, 7-dehydro[26-14C]cholesterol and 26-hydroxy[26-14C]cholesterol. Biochem J (1966) 0.83
Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83
The cyclo-oxygenase inhibitor, piroxicam, enhances cytokine-induced lymphocyte proliferation in vitro and in vivo. Immunol Cell Biol (1990) 0.83
Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83
Irritancy and anti-inflammatory activity of bis(eta 5-cyclopentadienyl)titanium(IV) complexes in rats. Chem Biol Interact (1987) 0.82
Synthesis and anti-inflammatory properties of some aromatic and heterocyclic aromatic curcuminoids. Bioorg Chem (2011) 0.82
Substrate and inhibitor specificity of the cholesterol oxidase in bovine adrenal cortex. Biochem J (1966) 0.82